| Name: | Bosutinib Impurity 38 |
| Catalogue No. | VE007447 |
| CAS No. | 2095306-26-4 |
| Molecular Formula | C46H44Cl4N8O6 |
| Molecular Weight | 946.7 g/mol |
| Status | In-Stock |
| IUPAC Name | 7,7'-((piperazine-1,4-diylbis(propane-3,1-diyl))bis(oxy))bis(4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxyquinoline-3-carbonitrile) |
| Description | Bosutinib Impurity 38 ( CAS No: 2095306-26-4 ) or 7,7'-((piperazine-1,4-diylbis(propane-3,1-diyl))bis(oxy))bis(4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxyquinoline-3-carbonitrile) is associate impurity of Bosutinib. Bosutinib is an active Src and Abl kinase inhibitor. Bosutinib is employed to treat a certain type of chronic myeloid leukemia |
| References | “Sci-Hub | Bosutinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the BELA Trial | 10.1200/JCO.2011.38.7522.” Hkvisa.net, 2012, sci-hub.hkvisa.net/10.1200/JCO.2011.38.7522. |
